APOTHEEK D. DUBOIS
ActiveAPOTHEEK D. DUBOIS has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €617k and a net result of €57k. Equity is growing by ~7.4% per year across the filed fiscal years. Its solvency ranks better than 50% of 4123 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
69
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability67▼-9
Solvency61▲+3
Growth78=
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity tight (current ratio 1.27 against 1.28 in 2024; short-term debt: 31.5% and cash: 11.3% of total assets), and 64.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
35.9%
Return on assets
3.3%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-08-2026, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
29 d late
2024
1 d late
2023
8 d early
2022
31 d late
2021
81 d early
2020
31 d late
2019
18 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
17-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€57k▼ 38.3%
2024 · €93k
2018: €38k
2019: €46k
2020: €39k
2021: €104k
2022: €96k
2023: €96k
2024: €93k
2018 → 2025
Working capital
€144k▲ 3.8%
2024 · €139k
2018: €359k
2019: €325k
2020: €301k
2021: €218k
2022: €39k
2023: €63k
2024: €139k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€436k-€411k▼ 5.5%€487k▲ 18.4%€560k▲ 15.0%€617k▲ 10.2%
Operating result€137k-€147k▲ 7.4%€150k▲ 2.1%€147k▼ 2.0%€103k▼ 29.7%
Net result€104k-€96k▼ 7.5%€96k▼ 0.2%€93k▼ 2.9%€57k▼ 38.3%
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 30% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.72M
Fixed assets
€1.03M▼ 4.4%
Current assets
€684k▲ 8.3%
Equity and liabilities €1.72M
Equity
€617k▲ 10.2%
Debt
€1.10M▼ 4.6%
The debt ratio falls from 67.3% to 64.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€155k▼
2024 · €199k
Cash flow
€109k▼
2024 · €145k
Solvency
35.9%▲
2024 · 32.7%
Current ratio
1.27▼
2024 · 1.28
Quick ratio
0.77▲
2024 · 0.70
Debt / equity
1.78▼
2024 · 2.06
ROE
9.3%▼
2024 · 16.6%
ROA
3.3%▼
2024 · 5.4%
Interest coverage
5.34▼
2024 · 6.17
Debt
€1.10M▼
2024 · €1.15M
Debt ≤ 1 year
€540k▲
2024 · €493k
Debt > 1 year
€555k▼
2024 · €654k
Income taxes
€21k▼
2024 · €26k
Staff costs
€281k▲
2024 · €262k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.71M€1.72M▲
Fixed assets21/28€1.08M€1.03M▼
Tangible fixed assets22/27€1.08M€1.03M▼
Land and buildings22€880k€847k▼
Plant, machinery and equipment23€17k€11k▼
Furniture and vehicles24€15k€12k▼
Other tangible fixed assets26€169k€162k▼
Current assets29/58€632k€684k▲
Stocks and contracts in progress3€286k€267k▼
Stocks30/36€286k€267k▼
Amounts receivable within one year40/41€180k€203k▲
Trade receivables40€165k€191k▲
Other amounts receivable41€16k€13k▼
Cash at bank and in hand54/58€161k€194k▲
Deferred charges and accrued income490/1€5k€19k▲
Equity and liabilities
Total equity and liabilities10/49€1.71M€1.72M▲
Equity10/15€560k€617k▲
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€498k€556k▲
Non-distributable reserves130/1€6k€6k=
Legal reserve130€6k€6k=
Tax-exempt reserves132€28k€28k=
Distributable reserves133€464k€521k▲
Amounts payable17/49€1.15M€1.10M▼
Amounts payable after more than one year17€654k€555k▼
Financial debts170/4€654k€555k▼
Amounts payable within one year42/48€493k€540k▲
Current portion of amounts payable after more than one year42€98k€99k▲
Financial debts43€7k-
Credit institutions430/8€7k-
Trade debts44€266k€318k▲
Suppliers440/4€266k€318k▲
Taxes, remuneration and social security45€45k€47k▲
Taxes450/3€6k€6k▲
Remuneration and social security454/9€39k€41k▲
Other amounts payable47/48€77k€76k▼
Accrued charges and deferred income492/3€6k€5k▼
Income statement
Code20242025
Remuneration, social security and pensions62€262k€281k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€52k€51k▼
Other operating charges640/8€5k€5k▲
Gross operating margin9900€467k€442k▼
Operating profit (loss)9901€147k€103k▼
Financial income75/76B€4k€3k▼
Recurring financial income75€4k€3k▼
Financial charges65/66B€32k€29k▼
Recurring financial charges65€32k€29k▼
Profit (loss) for the period before taxes9903€119k€78k▼
Income taxes67/77€26k€21k▼
Profit (loss) for the period9904€93k€57k▼
Profit (loss) for the period to be appropriated9905€93k€57k▼
Appropriation of the result
Profit (loss) to be appropriated9906€93k€57k▼
Transfer to equity691/2€73k€57k▼
To other reserves6921€73k€57k▼
Profit to be distributed694/7€20k-
Directors or managers695€20k-
Social balance
Average headcount (FTE)90873.53.1▼
The notes to these accounts (16 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-08
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 29 days late
2025
01-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 1 day late
2024
31-12
Financial
Equity above €500kEq €560k ▲15%
7 profitable years in a row build equity to €560k.
23-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 31 days late
2022
11-05
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Highest result since 2018net €104k ▲166%
Net result €104k, the highest in the series.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 31 days late
2020
18-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 18 days late
2019
07-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 7 days late
2018
17-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 17 days late
2017
28-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kortrijk · 1 establishment unit since 1991
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Izegemsestraat(Heu) 1318501 KortrijkGround area
266 m²
Building footprint
248 m²
Volume, LiDAR
1,350 m³
Parcel 34016C0502/00W000, Flanders · tallest building 10.1 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK D. DUBOIS
since 19912.052.397.660
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34016C0502/00W000 | Flanders | 266 m² | 1 · 248 m² | 10.1 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 to 2024 · 2 entries · 213 EUR awarded · 213 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2024 | 1 | 0 EUR | 213 EUR |
| 2023 | 1 | 213 EUR | 0 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Food safety, FASFC
1 siteKortrijk2.052.397.660
Similar companies · same sector, comparable size
PHARMACIE CATRIN
BE 0472.241.926
Charleroi · Eq €617k
APOTHEKER STEVEN VRIJDAG
BE 0817.319.624
Dendermonde · Eq €618k
Pharma Invest Devos
BE 0899.883.252
Halle · Eq €618k
PHARMACIE CRUNENBERG-GILLET
BE 0844.540.101
Stavelot · Eq €616k
MOERMAN ANN
BE 0808.468.175
Knokke-Heist · Eq €619k
Of 5,224 companies in sector 47730 we hold annual accounts for 3,864. 3,281 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded21-12-1990
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
68201Renting and operating of own or leased residential real estate, excluding social housing
Sources
Crossroads Bank for EnterprisesNational Bank · 35 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.